tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market

Oncopeptides AB (ONCO) Ratios

Compare
8 Followers

Oncopeptides AB Ratios

SE:ONCO's free cash flow for Q2 2025 was kr0.98. For the 2025 fiscal year, SE:ONCO's free cash flow was decreased by kr and operating cash flow was kr-2.93. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.42 4.23 4.52 4.25 1.83
Quick Ratio
3.27 4.14 4.46 4.25 1.83
Cash Ratio
2.64 3.48 3.86 4.02 1.61
Solvency Ratio
-1.31 -1.45 -1.31 -3.52 -6.17
Operating Cash Flow Ratio
-5.80 -5.07 -6.22 -4.91 -6.73
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 11.78
Net Current Asset Value
kr -13.38Mkr 27.17Mkr 21.30Mkr 273.00Mkr 183.87M
Leverage Ratios
Debt-to-Assets Ratio
0.60 0.58 0.53 0.02 0.03
Debt-to-Equity Ratio
19.30 2.61 2.22 0.03 0.07
Debt-to-Capital Ratio
0.95 0.72 0.69 0.03 0.06
Long-Term Debt-to-Capital Ratio
0.95 0.69 0.65 0.00 0.00
Financial Leverage Ratio
32.32 4.50 4.20 1.31 2.08
Debt Service Coverage Ratio
-11.75 -20.71 -40.15 -362.27 11.02
Interest Coverage Ratio
-11.70 -22.40 -43.81 -395.64 -1.50K
Debt to Market Cap
0.20 0.47 0.15 0.00 -0.29
Interest Debt Per Share
0.65 0.93 1.04 0.13 0.20
Net Debt to EBITDA
0.09 0.14 0.20 1.05 0.25
Profitability Margins
Gross Profit Margin
97.88%91.59%103.06%99.93%55.09%
EBIT Margin
-393.84%-858.04%-688.99%-4031.08%-1200.75%
EBITDA Margin
-393.84%-827.24%-657.64%-3825.43%-1182.69%
Operating Profit Margin
-393.84%-895.78%-719.61%-4181.33%-1201.16%
Pretax Profit Margin
-426.37%-898.03%-705.41%-4041.65%-1201.55%
Net Profit Margin
-428.01%-899.29%-707.30%-4044.90%-1209.11%
Continuous Operations Profit Margin
-428.01%-899.29%-707.30%-4044.90%-1209.11%
Net Income Per EBT
100.38%100.14%100.27%100.08%100.63%
EBT Per EBIT
108.26%100.25%98.03%96.66%100.03%
Return on Assets (ROA)
-126.77%-116.55%-104.50%-87.71%-325.53%
Return on Equity (ROE)
9005.99%-524.28%-438.73%-114.83%-678.30%
Return on Capital Employed (ROCE)
-158.69%-147.01%-131.02%-116.59%-663.71%
Return on Invested Capital (ROIC)
-158.69%-141.67%-131.37%-114.39%-1484.09%
Return on Tangible Assets
-126.77%-116.55%-104.50%-87.71%-326.58%
Earnings Yield
-40.39%-109.62%-35.97%-47.41%-317.14%
Efficiency Ratios
Receivables Turnover
1.79 2.84 16.05 0.00 9.96
Payables Turnover
0.11 0.15 -0.07 <0.01 1.49
Inventory Turnover
0.16 0.61 -0.44 0.00 53.12M
Fixed Asset Turnover
3.14 1.17 1.02 0.41 4.78
Asset Turnover
0.30 0.13 0.15 0.02 0.27
Working Capital Turnover Ratio
0.68 0.20 0.16 0.04 0.33
Cash Conversion Cycle
-845.81 -1.76K 4.29K -1.72M -208.68
Days of Sales Outstanding
204.29 128.47 22.74 0.00 36.63
Days of Inventory Outstanding
2.32K 599.10 -820.32 0.00 <0.01
Days of Payables Outstanding
3.37K 2.49K -5.08K 1.72M 245.31
Operating Cycle
2.53K 727.57 -797.58 0.00 36.63
Cash Flow Ratios
Operating Cash Flow Per Share
-1.44 -1.57 -2.20 -5.11 -20.14
Free Cash Flow Per Share
-1.44 -1.57 -2.20 -5.14 -20.14
CapEx Per Share
<0.01 <0.01 <0.01 0.03 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-909.55 -729.89 -2.41K -167.73 -4.47K
Capital Expenditure Coverage Ratio
-909.55 -729.89 -2.41K -167.73 -4.47K
Operating Cash Flow Coverage Ratio
-2.57 -1.84 -2.22 -44.07 -106.84
Operating Cash Flow to Sales Ratio
-5.19 -8.23 -7.94 -50.33 -12.82
Free Cash Flow Yield
-51.28%-100.36%-40.38%-59.34%-336.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.48 -0.91 -2.78 -2.11 -0.32
Price-to-Sales (P/S) Ratio
10.12 8.20 19.66 85.33 3.81
Price-to-Book (P/B) Ratio
101.42 4.78 12.20 2.42 2.14
Price-to-Free Cash Flow (P/FCF) Ratio
-1.95 -1.00 -2.48 -1.69 -0.30
Price-to-Operating Cash Flow Ratio
-2.04 -1.00 -2.48 -1.70 -0.30
Price-to-Earnings Growth (PEG) Ratio
-1.57 0.07 0.05 0.03 0.01
Price-to-Fair Value
101.42 4.78 12.20 2.42 2.14
Enterprise Value Multiple
-2.48 -0.85 -2.79 -1.18 -0.07
Enterprise Value
611.55M 222.82M 645.27M 377.92M 103.01M
EV to EBITDA
-2.48 -0.85 -2.79 -1.18 -0.07
EV to Sales
9.77 7.04 18.32 45.23 0.87
EV to Free Cash Flow
-1.88 -0.86 -2.31 -0.89 -0.07
EV to Operating Cash Flow
-1.88 -0.86 -2.31 -0.90 -0.07
Tangible Book Value Per Share
0.03 0.33 0.45 3.57 2.78
Shareholders’ Equity Per Share
0.03 0.33 0.45 3.57 2.80
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
0.28 0.19 0.28 0.10 1.57
Net Income Per Share
-1.19 -1.71 -1.96 -4.11 -19.00
Tax Burden
1.00 1.00 1.00 1.00 1.01
Interest Burden
1.08 1.05 1.02 1.00 1.00
Research & Development to Revenue
1.76 3.83 3.04 26.05 5.75
SG&A to Revenue
1.00 1.92 1.96 10.06 1.48
Stock-Based Compensation to Revenue
0.00 0.00 0.00 2.29 -0.29
Income Quality
1.21 0.92 1.12 1.20 1.07
Currency in SEK